|
Variables entered
|
PCS
| | |
MCS
| | |
CLDQ
| | |
|---|
| |
β(SE)
|
P
|
b
|
β(SE)
|
P
|
b
|
β(SE)
|
P
|
b
|
|---|
|
Treatment duration (<8 weeks as reference)
| | | | | | | | | |
|
9–16 weeks
|
-9.38(2.69)
|
0.00
|
-0.33
|
0.66(2.81)
|
0.82
|
0.02
|
-0.32(0.22)
|
0.16
|
-0.15
|
|
>17 weeks
|
-3.83(2.88)
|
0.19
|
-0.13
|
1.56(3.00)
|
0.60
|
0.05
|
0.09(0.24)
|
0.72
|
0.04
|
|
Monthly income (≤NT$10,000 as reference)
| | | | | | | | | |
|
>NT$30,000
|
8.47(3.54)
|
0.02
|
0.33
|
8.79(3.69)
|
0.02
|
0.35
|
0.68(0.29)
|
0.02
|
0.34
|
|
NT$10,001 ~ 30000
|
5.69(3.39)
|
0.10
|
0.19
|
7.13(3.54)
|
0.05
|
0.24
|
0.37(0.28)
|
0.19
|
0.16
|
|
Gender (female as reference)
|
4.39(2.44)
|
0.08
|
0.18
|
4.80(2.54)
|
0.06
|
0.20
|
0.43(0.20)
|
0.04
|
0.23
|
|
R2
|
0.28
| | |
0.16
| | |
0.16
| | |
- β = regression coefficient, b = standardized regression coefficient, SE = standard error.
- **Adjusted for age, gender, marital status, education, current employment, and serum ALT level.
